Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-nucleolin agent-conjugated nanoparticles as radio-sensitizers and MRI and/or X-ray contrast agents

Anti-nucleolin agent-conjugated nanoparticles as radio-sensitizers and MRI and/or X-ray contrast agents

US Patent 10857237 · Granted Dec 8, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ophthalmic compositions and methods for reducing oxidative damage to an eye lens2025
Compositions and methods for reducing oxidative damage2025
Compositions and methods for reducing oxidative damage2023
Methods for treating diseases2023
Ophthalmic compositions and methods for reducing oxidative damage to an eye lens2022
Anti-nucleolin agent-conjugated nanoparticles2022
Anti-nucleolin agent-conjugated nanoparticles2022
Compounds, compositions, methods for treating diseases, and methods for preparin2021
Compositions and methods for reducing oxidative damage2019
Method for synthesizing self-assembling nanoparticles2018
Compositions and methods for modulating DNMT1 inhibitor activity2017
Compositions and methods for reducing oxidative damage2017